Technische Universität Dresden

Survival and patient satisfaction of short implants during the first 2 years of function: a retrospective cohort study with 694 implants in 416 patients (2016) Hentschel A, Herrmann J, Glauche I, Vollmer A, Schlegel KA, Lutz R Journal article Spatially Resolved Genome-wide Transcriptional Profiling Identifies BMP Signaling as Essential Regulator of Zebrafish Cardiomyocyte Regeneration (2016) Wu CC, Kruse F, Vasudevarao MD, Junker JP, Zebrowski D, Fischer K, Noel ES, et al. Journal article Which factors are associated with the use of systemic antihistamines in patients with chronic hand eczema? Results from the CARPE registry (2016) Apfelbacher C, Weiss M, Molin S, Bauer A, Mahler V, Schmitt J, Elsner P, et al. Journal article Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction (2016) Klingelhoefer E, Bergert H, Kersting S, Ludwig S, Weiss N, Schoenleben F, Grützmann R, Gaebel G Journal article Surgery for metastases, anatomical and ethical limits : Special aspect: oligometastases (2016) Perrakis A, Juratli TA, Hohenberger W, Croner RS, Schackert G Journal article Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy (2016) Werner K, Lademann F, Thepkaysone ML, Jahnke B, Aust D, Kahlert C, Weitz J, et al. Journal article A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2 (2016) Rodionov RN, Oppici E, Martens-Lobenhoffer J, Jarzebska N, Brilloff S, Burdin D, Demyanov A, et al. Journal article Validation of standardized questionnaires evaluating symptoms of depression in rheumatoid arthritis patients - approaches to screening for a frequent and yet underrated challenge (2016) Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, Fliedner G, et al. Journal article Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011 (2016) Schoffer O, Schuelein S, Arand G, Arnholdt H, Baaske D, Bargou RC, Becker N, et al. Journal article Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study (2016) Stallmach A, Langbein C, Atreya R, Bruns T, Dignass A, Ende K, Hampe J, et al. Journal article